Patients Achieved Remission Within 30 Days in Cohort 1 of the Mipletamig RAINIER Dose Optimization Trial for Frontline AML Patients, Trial Enrollment Continues Promising Data, including a 59% Stable ...
Data for the month of January shows that the stoppage ratio surged to nearly 109 percent, a significant jump from 82.73 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback